União Química
Date: Feb 2015
Client: União Química
Counterparty: Novartis
Industry: Healthcare
Amount: Undisclosed amount
Transaction:
Landmark Alantra acted as exclusive financial advisor of União Química Farmacêutica Nacional, one of Brazil´s biggest pharmaceutical companies, in the acquisition of a manufacturing site from Novartis, one of world´s biggest pharmaceuticals. This plant manufactures medicines to supply the Latin American market.
Besides the acquisition of the asset, the transaction also included a long term manufacturing agreement of Novartis medicines by União Química.
Feb 2015
Financial advisor to
on the acquisition of the Taboao da Serra/SP plant from
Undisclosed amount
Similar transactions
Nov 2021
Financial advisor to
on the sale of 34% of the shares to
With this transaction, Virbac completes the acquisition of 100% of the company since the initial purchase in 2012
Leer más
